1995
DOI: 10.1210/jcem.80.10.7559896
|View full text |Cite
|
Sign up to set email alerts
|

Aromatase activity and interleukin-6 production by normal and malignant breast tissues.

Abstract: The aromatase enzyme complex, which regulates the conversion of androstenedione to estrone, may have an important role in regulating estrogen synthesis in breast tissues. In this study the effect of tumor location on aromatase activity in adjacent tissue was examined and related to interleukin-6 (IL-6) production, which has been shown to stimulate aromatase activity in breast cancer cells. Samples of normal and malignant breast tissues were obtained from 11 women undergoing mastectomy. In 7 patients, aromatase… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
65
1
2

Year Published

1999
1999
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(70 citation statements)
references
References 22 publications
2
65
1
2
Order By: Relevance
“…Purohit et al (1995) hypothesized that IL6 modulates the reaction of aromatase, a key regulatory enzyme for estrogen metabolism, influencing satiety and adipose tissue distribution. IL6 was also reported to be the second most secreted protein "hormone" to be released by human subcutaneous AT, supporting the hypothesis of the role of this Results are expressed as mean Ϯ SD.…”
Section: Discussionmentioning
confidence: 99%
“…Purohit et al (1995) hypothesized that IL6 modulates the reaction of aromatase, a key regulatory enzyme for estrogen metabolism, influencing satiety and adipose tissue distribution. IL6 was also reported to be the second most secreted protein "hormone" to be released by human subcutaneous AT, supporting the hypothesis of the role of this Results are expressed as mean Ϯ SD.…”
Section: Discussionmentioning
confidence: 99%
“…Both cytokines are expressed in, and released by, adipose tissue. [13][14][15][16] We have recently reported significant in vivo release of IL-6, but not TNF-␣, by a subcutaneous adipose tissue depot. 13 However, the relationships of circulating concentrations of TNF-␣ with obesity suggests that adipose tissue, perhaps in other sites, may contribute to circulating levels.…”
Section: Yudkin Et Al April 1999 975mentioning
confidence: 99%
“…13 The production of IL-6, as well as systemic concentrations, increase with adiposity, and we have estimated that Ϸ30% of total circulating concentrations of IL-6 originate from adipose tissue in healthy subjects. 13 Both IL-6 and tumor necrosis factor-␣ (TNF-␣) are expressed in adipose tissue 14,15 and in vitro release of TNF-␣ by adipocytes has been reported. 16 Among the known effects of these cytokines are inhibition of insulin signaling 17 and induction of both hypertriglyceridemia 18 and endothelial activation.…”
mentioning
confidence: 99%
“…Since the high-sensitivity method for measuring CRP levels was introduced a few years ago, more accurate and precise relationships between CVD and CRP are being identified [1]. Adipose tissue, one of risk factors for atherosclerosis, is closely associated with inflammation by secreting proinflammatory cytokines [2,3]. Moreover, these proinflammatory cytokines control the synthesis of CRP [4].…”
Section: Introductionmentioning
confidence: 99%